CRO Services Center (Phase I-III)
Clinical Trials are required for drug therapies to receive regulatory approval.
A Phase 1 trial is the first to involve human subjects, and their objective is to determine the highest does of a treatment that can be safely administered to patients. A Phase 2 trial is conducted on a small number of patients to determine if the drug is effective. If the Phase 1 and Phase 2 trials are successful, a larger Phase 3 trial is conducted to gather data to present to the FDA. In a Phase 3 trial a drug is often tested against a placebo or the current standard of care. Clinical trials are expensive and time consuming, and they require expertise in many areas. Sponsors need to perform study startup (which includes site selection and patient recruitment), manage and oversee the trial, and collect and analyze trial data. All of these operations can be performed by a CRO.
How can we help?
Looking for help with your Phase I-III project? If you're searching for information or a supplier, let Clinical Leader lend you a hand.
Catalyst Clinical Research
Catalyst Clinical Research is a clinical development organization providing highly customizable solutions to the global biopharmaceutical industry. Built from more than two decades of listening to their customers, devising customer-centric solutions and helping them breakthrough with clinical development programs surrounded by therapeutically aligned teams of experts.
Now more than ever, the clinical development path is full of make-or-break data complexities and analytical challenges. As a pioneer in evidence generation, with deep expertise in advanced analytical solutions, we are uniquely equipped to unlock the value from increasingly complex data. Life Sciences companies count on Cytel to deliver exceptional insight, minimize trial risk and accelerate the development of promising new medicines that improve human life.
Parexel is in the business of improving the world’s health. We do this by providing a suite of biopharmaceutical services that help clients across the globe transform scientific discoveries into new treatments. From clinical trials to regulatory, consulting, and market access, our therapeutic, technical, and functional ability is underpinned by a deep conviction in what we do.
Premier Research recognizes that when an emerging biotech is built around a single asset, focus and flexibility are critical to success. And, since many of our customers require additional infrastructure, we fill in resourcing gaps to help their product reach the patient faster. We are a mid-size CRO and offer strategies that are customized for each program, with tailored processes designed to meet highly specific needs.
Rho is a privately-held contract research organization (CRO) located in Chapel Hill, NC. We provide a full range of clinical research services across the entire drug development process. For 30 years, we’ve been a trusted partner to some of the industry’s leading pharmaceutical, biotechnology, and medical device companies as well as academic and government organizations.
United BioSource - UBC
United BioSource LLC (UBC) is a leading provider of pharmaceutical support services, partnering with life science companies to make medicine and medical products safer and more accessible. UBC is well known for our expertise in generating authoritative, real-world evidence of product effectiveness, safety, and value to assist healthcare decisions and enhance patient care.
Worldwide Clinical Trials
Founded by physicians committed to advancing medical science, Worldwide is out to change how the world experiences CROs – in the best possible way. From early phase and bioanalytical sciences through late phase, post-approval and real-world evidence, we provide world-class, full-service drug development services across a range of therapeutic areas, including central nervous system, cardiovascular, metabolic, general medicine, oncology and rare diseases. We never compromise on science or safety. We’re never satisfied with the status quo. We’re the Cure for the Common CRO.